• Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors 

      Serrano, José M.; Mata, Rebeca; González, Iria; Del Castillo, Silvia; Muñiz, Javier; Morales, Luis J.; Espinosa, María Jesús; Moreno, Fernando; Jiménez, Rosa; Cristóbal, Carmen; Graupner, Catherine; Talavera, Pedro; Gutiérrez Landaluce, Carlos; Curcio, Alejandro; Alonso, Javier; Guerra, Juan A.; Alonso, Joaquín J. (Elsevier, 2023-04-18)
      [Abstract] Introduction. Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data on longitudinal studies about early and late onset cardiotoxicity in this ...